Triclabendazole

Kathryn Dzintars, PharmD, BCPS
Triclabendazole is a topic covered in the Johns Hopkins ABX Guide.

To view the entire topic, please or purchase a subscription.

Official website of the Johns Hopkins Antibiotic (ABX), HIV, Diabetes, and Psychiatry Guides, powered by Unbound Medicine. Johns Hopkins Guide App for iOS, iPhone, iPad, and Android included. Explore these free sample topics:

Johns Hopkins Guides

-- The first section of this topic is shown below --

INDICATIONS

FDA

Triclabendazole is not currently FDA approved for use in the United States.

  • Available through the CDC under an investigational drug protocol
  • Triclabendazole is included on the WHO Essential Drug List for the management of fascioliasis.

-- To view the remaining sections of this topic, please or purchase a subscription --

Last updated: October 25, 2016

Citation

* When formatting your citation, note that all book, journal, and database titles should be italicized* Article titles in AMA citation format should be in sentence-case
TY - ELEC T1 - Triclabendazole ID - 540674 A1 - Dzintars,Kathryn,PharmD, BCPS Y1 - 2016/10/25/ PB - Johns Hopkins ABX Guide UR - https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_ABX_Guide/540674/all/Triclabendazole ER -